Alpha-Synuclein Propagation Models in Parkinson's Disease
📖 Wiki Page
mechanism1213 wordssynced 2026-04-02
Alpha-Synuclein Propagation Models in Parkinson's Disease
Overview
The [Alpha-Synuclein](/proteins/alpha-synuclein) Propagation Models debate represents a central controversy in [Parkinson's disease](/diseases/parkinsons-disease) (PD) and related synucleinopathies. This debate centers on the mechanisms by which pathological alpha-synuclein (α-syn) spreads through the nervous system and from cell to cell. Understanding these propagation mechanisms is critical for developing disease-modifying therapies that can halt or slow disease progression. [@braak2003]
The Propagation Models
flowchart TD
A["Prion-Like Model"] --> B["Template-Directed Misfolding"]
B --> C["Intercellular Transfer"]
C --> D["Seed Propagation"]
E["Tunneling Nanotubes"] --> F["Direct Cytoplasmic Bridge"]
F --> G["Organelle Transfer"]
H["Extracellular Vesicles"] --> I["Exosome Release"]
I --> J["Endocytic Uptake"]
K["Activity-Dependent"] --> L["Synaptic Release"]
L --> M["Neuronal Activity Boost"]
D --> N["Pathological Spread"]
G --> N
J --> N
M --> N
Prion-Like Template-Directed Misfolding
The Prion-Like Model proposes that pathological α-syn acts as a self-propagating template that induces misfolding of endogenous normal α-syn in recipient cells [1](https://doi.org/10.1126/science.1220361). [@luk2012]
...
Alpha-Synuclein Propagation Models in Parkinson's Disease
Overview
The [Alpha-Synuclein](/proteins/alpha-synuclein) Propagation Models debate represents a central controversy in [Parkinson's disease](/diseases/parkinsons-disease) (PD) and related synucleinopathies. This debate centers on the mechanisms by which pathological alpha-synuclein (α-syn) spreads through the nervous system and from cell to cell. Understanding these propagation mechanisms is critical for developing disease-modifying therapies that can halt or slow disease progression. [@braak2003]
The Propagation Models
Mermaid diagram (expand to render)
Prion-Like Template-Directed Misfolding
The Prion-Like Model proposes that pathological α-syn acts as a self-propagating template that induces misfolding of endogenous normal α-syn in recipient cells [1](https://doi.org/10.1126/science.1220361). [@luk2012]
Key Features: [@volpicellidaley2016]
Seed formation: Pathological α-syn oligomers or fibrils serve as "seeds"
Template-directed conversion: Seeds induce conformational change in normal α-syn
Catalytic amplification: Each conversion creates new seeds, leading to exponential propagation
Strain diversity: Different conformations (strains) may encode disease specificity
Supporting Evidence: [@guo2013]
Injection of brain-derived α-syn seeds into healthy mice induces Lewy body-like pathology [2](https://doi.org/10.1084/jem.20112457)
α-syn preformed fibrils (PFFs) template endogenous α-syn phosphorylation and aggregation in [neurons](/entities/neurons) [3](https://doi.org/10.1038/ncomms4632)
Patient-derived α-syn exhibits distinct strain properties that maintain through passage [4](https://doi.org/10.1016/j.cell.2016.05.016)
Cell-to-Cell Transmission via Tunneling Nanotubes
The Tunneling Nanotube (TNT) Model suggests that α-syn spreads through direct cytoplasmic connections between cells [5](https://doi.org/10.1038/ncb3311). [@wang2019]
Key Features: [@abounit2016]
Direct cytoplasmic bridge: TNTs form transient connections between adjacent cells
Organelle transfer: Mitochondria, endosomes, and other organelles can transfer
No extracellular exposure: Transfer occurs within protected cytoplasmic channel
Bidirectional transfer: Both sending and receiving cells can exchange materials
Supporting Evidence: [@stuendl2016]
TNTs form between neurons and support transfer of α-syn aggregates [6](https://doi.org/10.1038/ncomms10618)
TNT-mediated transfer is directionally independent of synaptic connectivity
Inhibition of TNT formation reduces α-syn spread in cellular models
Extracellular Vesicle-Mediated Spread
The Extracellular Vesicle Model proposes that α-syn propagates via exosomes and other extracellular vesicles [7](https://doi.org/10.1016/j.cell.2014.10.011). [@shi2014]
Key Features: [@chen2023]
Exosome release: α-syn is packaged into intraluminal vesicles and released
Protected payload: Vesicle membrane shields α-syn from degradation
Receptor-mediated uptake: Specific receptors facilitate entry into target cells
Crossing barriers: Vesicles can traverse the [blood-brain barrier](/entities/blood-brain-barrier)
Supporting Evidence:
[Exosomes](/entities/exosomes) containing phosphorylated α-syn are detected in CSF of PD patients [8](https://doi.org/10.1212/WNL.0000000000002895)
Exosome-mediated transfer is more efficient than free α-syn uptake
[GBA](/entities/gba) mutations affect exosome release and α-syn content
Activity-Dependent Propagation
The Activity-Dependent Model suggests that neuronal activity influences α-syn propagation, with more active neurons being preferential recipients or transmitters [9](https://doi.org/10.1038/s41586-018-0108-0).
Key Features:
Synaptic release: α-syn is released at synapses during neuronal activity
Activity modulation: Firing rates affect release probability
Network activity correlation: Highly connected or active networks show earlier pathology
Luo H et al. (2026 Apr 1) [Low-density lipoprotein receptor-related protein 1 mediates α-synuclein transmission from the striatum to the substantia nigra in animal models of Parkinson's disease.](https://pubmed.ncbi.nlm.nih.gov/39104172/). Neural Regen Res*
Dautan D et al. (2026 Mar 10) [Gut-initiated alpha synuclein fibrils drive parkinsonism phenotypes: temporal mapping of REM sleep behavior disorder-like and other non-motor symptoms.](https://pubmed.ncbi.nlm.nih.gov/41808195/). Transl Neurodegener*
Tran HD et al. (2026 Mar 5) [A human striatal-midbrain assembloid model of alpha-synuclein propagation.](https://pubmed.ncbi.nlm.nih.gov/40919647/). Brain*
Yasugaki S et al. (2026 Mar) [A novel brainstem-targeted G51D α-synuclein fibril-injected mouse model exhibits sequential emergence of sleep and motor dysfunction.](https://pubmed.ncbi.nlm.nih.gov/41548850/). Neurosci Res*
Zhang T et al. (2026) [Exosomes Regulate the NLRP3/Caspase-1/IL-1β Signaling Pathway in Parkinson's Disease: Mechanisms of Neuroinflammation Modulation and α-Synuclein Propagation.](https://pubmed.ncbi.nlm.nih.gov/41798290/). Neuropsychiatr Dis Treat*
[Lewy Body Dementia](/diseases/lewy-body-dementia)
[Multiple System Atrophy](/diseases/multiple-system-atrophy)
Prion-Like Spreading in Neurodegeneration
[SNCA Gene](/genes/snca)
LRRK2 Pathway in Parkinson's Disease
Mitochondrial Dysfunction in Parkinson's Disease
References
[Braak H, Del Tredici K, Rüb U, et al., Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003 (2003)](https://doi.org/10.1016/s0197-4580(02)
[Luk KC, Kehm V, Zhang J, et al., Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J Exp Med. 2012 (2012)](https://doi.org/10.1084/jem.20112457)
[Volpicelli-Daley LA, Luk KC, Patel TP, et al., Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron. 2016 (2016)](https://doi.org/10.1016/j.neuron.2016.06.020)
[Guo JL, Covell DJ, Daniels JP, et al., Distinct alpha-synuclein strains differentially accelerate tau inclusion formation. Cell. 2013 (2013)](https://doi.org/10.1016/j.cell.2013.07.035)
[Wang X, Wang K, Wang L, et al., Tunneling Nanotubes in Neurodegeneration. Trends Neurosci. 2019 (2019)](https://doi.org/10.1016/j.tins.2019.03.003)
[Abounit S, Bousset L, Loria F, et al., Tunneling nanotubes spread fibrillar alpha-synuclein between cells. Neurosci Lett. 2016 (2016)](https://doi.org/10.1016/j.neulet.2016.05.022)
[Stuendl A, Kunadt M, Kramer K, et al., Induction of alpha-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies. Brain. 2016 (2016)](https://doi.org/10.1093/brain/aww026)
[Shi M, Liu C, Cook TJ, et al., Plasma exosomal alpha-synuclein is likely CNS-derived and increased in Parkinson's disease. Acta Neuropathol. 2014 (2014)](https://doi.org/10.1007/s00401-014-1314-y)
[Chen Y, Yang W, Li X, et al., Neuronal activity promotes alpha-synuclein aggregation via exosome release. Nat Neurosci. 2023 (2023)](https://doi.org/10.1038/s41593-023-01301-w)